Nidaullah Mian, MD
Neurology · Lafayette, LANPI 1700295953
Payments from drug & device makers
What this record shows
This record is dominated by grants: $7,500 of the $9,318 with a category attached, or 80.5%. Medtronic accounts for 83.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $8,124 and has fallen 98.8% since, to $98 in 2025.
Across 49 payments — averaging $190.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Abbott$283
- Teva Pharmaceuticals USA, Inc.$252
- Acorda Therapeutics, Inc$217
- AbbVie$192
- Amgen$160
- plus $457 from 9 others
What the payments were for
- Speaking & faculty fees$1161%
- Grants$7,50080%
- Food & beverage$1,70218%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 6 | $7,757 |
| Abbott | 4 | $283 |
| Teva Pharmaceuticals USA, Inc. | 3 | $252 |
| Acorda Therapeutics, Inc | 6 | $217 |
| AbbVie(2 entities) | 9 | $192 |
| Amgen(2 entities) | 7 | $160 |
| Greenwich Biosciences, Inc. | 1 | $129 |
| Lundbeck LLC | 1 | $110 |
| Neurocrine Biosciences, Inc. | 4 | $83 |
| Biogen | 2 | $37 |
| Amneal Pharmaceuticals LLC | 2 | $27 |
| UCB, Inc. | 1 | $20 |
| Impel Pharmaceuticals Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $17 |
| CSL Behring | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,318 in reported general payments places this provider in the 70th percentile of 225 neurology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Lafayette
- Fabian LugoLafayette$27K
- Kevin HargraveLafayette$21K
- Virginia KellnerLafayette$18K
- Sahil ThankiLafayette$18K
- Steven SnaticLafayette$15K
- Thomas PrivettLafayette$15K
- Adam ForemanLafayette$12K
- Jonathan JonesLafayette$12K
- Wael AlabdulkarimLafayette$11K
- Tiffany LiuLafayette$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.